Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health ...

Getting the HPV vaccine in early adolescence may lower the risk of HPV-related cancers before exposure occurs. Learn about ...

More than 1,500 people who have sought support from the vaccine damage payment scheme after being injured or bereaved as a ...

Hospitalizations and general "syndromic" cases were at 10+ statewide for the week. The number of reported COVID cases ...

Shares of Moderna (NASDAQ: MRNA) zoomed as much as 33.3% higher this week, according to data from S&P Global Market ...

Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.

Share prices of Moderna (NASDAQ: MRNA) plummeted 58% in 2024, ranking among the worst performers in the S&P 500 index. The ...

Booster Now ... can be prevented with only two shots of improved vaccine, with a third shot later to give “prolonged immunity.” Contact us at [email protected] ...

In July, the company received US$176 million from the US government to speed development of the vaccine, which uses messenger RNA, the same technology that allowed quick development of Covid-19 shots.

Moderna also will design up to four additional novel pandemic influenza vaccines and test preliminary safety and immunogenicity (generating an immune system response) in phase 1 clinical studies.

Just six months earlier, Trump had declared the COVID vaccines a miracle. At the time that Kennedy filed the petition ... were 14 times the rates of those who had received a COVID booster shot.